Assistant Professor of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania
Radiation Oncology
Dr. Jay F. Dorsey, MD
|
|
Give Review
Dr. Jay F. Dorsey is an expert in the field of Radiation Oncology. She graduated from University of South Florida College of Medicine. University of South Florida College of Medicine is ranked 79 in research and 85 in primary care medicine She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dorsey has written publications. She has 37 publications published with PubMed. The lastest paper is: 'Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases.'
Publications
- A Multifunctional Nanoplatform for Imaging, Radiotherapy, and the Prediction of Therapeutic Response.
- Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer patients undergoing definitive radiation therapy: Pilot study resu...
- Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: A case study.
- Gamma Knife radiosurgery to four or more brain metastases in patients without prior intracranial radiation or surgery.
- Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay.
- Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells.
- Gold-Loaded Polymeric Micelles for Computed Tomography-Guided Radiation Therapy Treatment and Radiosensitization.
- Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors.
- A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme.
- Enhancing the Efficacy of Drug-loaded Nanocarriers against Brain Tumors by Targeted Radiation Therapy.
- Dissecting the complex regulation of Mad4 in glioblastoma multiforme cells.
- An integrated method for reproducible and accurate image-guided stereotactic cranial irradiation of brain tumors using the small animal radiation research platform.
- IL-13R?2-Targeted Therapy Escapees: Biologic and Therapeutic Implications.
- Modulation of chop-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
- Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3{beta} and CDK1.
- A glimpse of the future: where will new combinations of diagnostics and therapies take us?
- Astrocyte-elevated gene-1 (AEG-1): Glioblastoma's helping hand during times of hypoxia and glucose deprivation?
- Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions.
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells.
- Role of PI3K/Akt signaling in TRAIL- and radiation-induced gastrointestinal apoptosis.
- FLIPing the apoptosis switch on in brain tumors using Troglitazone and TRAIL.
- SRC directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis.
- Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cells.
- Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation.
- Multimodality optical imaging and 18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenografts.
- Aloe(-emodin) for cancer? More than just a comforting salve.
- Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2.
- Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases.
- A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells.
- Selective Targeting of Brain Tumors With Nanoparticle-induced Radiosensitization and Contrast Enhancement.
- Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.
- (18)F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.
- Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors.
- The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells.
- Requirement of SHP2 binding to Grb2-associated binder-1 for mitogen-activated protein kinase activation in response to lysophosphatidic acid and epidermal growth factor.
- Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
Schools
University of South Florida College of Medicine
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Wake Forest University -
University of Pennsylvania Health System -
University of South Florida -
University of South Florida College of Medicine
Hospital
-
Hospital of the University of Pennsylvania -
Philadelphia Veterans Affairs Medical Center -
Pennsylvania Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851457618 |
| Last Name Of The Provider | DORSEY |
| First Name Of The Provider | JAY |
| View All |
Similar Doctors
|
|
Dr. Alexander M. Lin, MD |
|
|
Dr. Min R. Cheung, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edgar Ben-Josef, MD |
|
|
Dr. Michelle Alonso-Basanta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amit Maity, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|